GenoGenix recalls Tirzepatide 60mg/10mL vials due to lack of sterility assurance. Affected lots may pose infection risks if used.
Lack of Assurance of Sterility
GenoGenix is recalling all Tirzepatide 60mg/10mL vials for injection because they lack sterility assurance. This could lead to infections if the product is used.
The vials lack assurance of sterility, meaning they might contain harmful bacteria or other contaminants. If injected, this could cause serious infections or health complications.
People who have the recalled vials for injection, particularly those using the product for medical treatment. Those with compromised immune systems may be at higher risk.
Check for vials labeled 'Tirzepatide 60mg/10mL for Injection' or 'Extension Health/Synergy Wellness 60mg, 10mL vial lyophilized'. The affected lots are GG012925-005 and GG021125-003.
Look for the lot numbers GG012925-005 or GG021125-003 on the vial label.
The recall states there is a lack of sterility assurance, so it is not safe to use. The product may contain harmful contaminants.
The recall record does not specify a remedy, so contact GenoGenix directly for guidance.
Check for the lot numbers GG012925-005 or GG021125-003 on the vial label.
We’ve drafted a message you can send GenoGenix to request your refund or repair — edit it as you like.
Subject: Recall D-0092-2026 — GenoGenix GenoGenix Hello, I own a GenoGenix that is covered by recall D-0092-2026 from GenoGenix. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
